FAIRFIELD, N.J., May 15 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. today announced that it will participate in the Bank of America 2006 Health Care Conference at the Four Seasons Hotel in Las Vegas, Nevada, from Tuesday, May 16 to Thursday, May 18, 2006.
Daniel Glassman, President and CEO, is scheduled to present on Tuesday, May 16, 2006 beginning at 4 p.m (PT). Mr. Glassman will discuss the Company’s financial and business performance.
A live audio webcast of Mr. Glassman’s presentation can be accessed by visiting http://www.veracast.com/webcasts/bas/healthcare06/id84112315.cfm, or www.bradpharm.com and clicking on Investor Relations, then Calendar of Events.
Bradley Pharmaceuticals, Inc. was founded in 1985 as a specialty pharmaceutical company and markets to niche physician specialties in the U.S. and 38 international markets. Bradley’s success is based on the strategy of Acquire, Enhance and Grow. Bradley Acquires non-strategic brands, Enhances these brands with line extensions and improved formulations and Grows the products through promotion, advertising and selling activities to optimize life cycle management. Bradley Pharmaceuticals is comprised of Doak Dermatologics, specializing in topical therapies for dermatology and podiatry; Kenwood Therapeutics, providing gastroenterology, respiratory and other internal medicine brands; and A. Aarons, which will market authorized generic versions of Doak and Kenwood therapies.
Please visit Bradley Pharmaceuticals web site at: www.bradpharm.com
Bradley Pharmaceuticals common stock is listed on the NYSE under the symbol BDY.
Bradley Pharmaceuticals, Inc.
CONTACT: Anthony Griffo, Investor Relations of Bradley Pharmaceuticals,Inc., +1-973-882-1505, ext. 313
Web site: http://www.bradpharm.com/
